about
Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu statusOverexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene clusterYoung age: an independent risk factor for disease-free survival in women with operable breast cancerLong-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testingThe pathology of familial breast cancer: Immunohistochemistry and molecular analysisUpdate on HER-2 as a target for cancer therapy: herceptin in the clinical setting.Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomasInduction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cellsPhosphosignature predicts dasatinib response in non-small cell lung cancer.Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinomaHER-2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies.Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.Updated UK Recommendations for HER2 assessment in breast cancer.Tissue and cell imaging in situ: potential for applications in pathology and endoscopyEvaluation of intratumoral HER-2 heterogeneity by fluorescence in situ hybridization in invasive breast cancer: a single institution studyThe pathology of hereditary breast cancer.Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma.Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancerPrecursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples.ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.Role of hormonal risk factors in HER2-positive breast carcinomas.Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancersExpression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.Comparison of chromogenic in situ hybridisation with fluorescence in situ hybridisation and immunohistochemistry for the assessment of her-2/neu oncogene in archival material of breast carcinoma.The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis.Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.Comparison of different detection methods in quantitative microdensitometry.A genome-inspired, reverse selection approach to aptamer discovery.
P2860
Q21195160-3F3AB857-C9C4-43DB-A985-725FB816DC52Q24670351-1648AECC-D173-4720-9906-C9697F4650F6Q24791855-946B79E4-0541-430C-B27D-3AE2872C9913Q24797752-F6E58C58-38A6-4EC4-B54E-59498AC1810CQ24800411-1CCE241B-D3A2-4B1A-82A9-C2A9BDA4BE6AQ24801924-88C2FA4F-0C3F-4BBA-82EF-669EFDF18EEBQ24810517-D2EE712E-1136-4DB6-8FB4-2885CC9040E6Q26865068-62FE7977-D3C7-4D38-9297-EC7E4D793BEEQ28478544-17F3D58C-AF3B-4BE4-A418-DB0390D7218FQ30524724-BD2210DF-E706-48C2-AEAB-09CD0A3D97D0Q30879242-A32F7189-7E08-4F63-B9AE-0E27B89098CEQ30959521-FB517B72-7DD3-4084-9F56-85B443254F8BQ33421127-C25742B3-AF93-417A-ABDF-17B5648CDDCFQ33631562-6B46615D-EB8D-41B8-8934-A24E728B6BFBQ34020212-7D521367-2FE5-426E-8147-8621C833D221Q34125003-3799F221-D952-49ED-85F0-DA84253190D8Q34486039-F3343738-530D-4FE0-871B-C7FD5104F5A4Q35048548-721FED41-8FAF-47AA-BCDF-6BD137FA3FF5Q35127197-26009B04-C907-4CD7-8317-C674F357EB4BQ35158754-325C6A8E-85F2-4B52-ABA3-3A6F6CEF2BCAQ35355084-B1F1FB3F-8528-4B03-804C-F6CB8E9F347DQ35700713-98C49A1F-7926-4768-A060-517872FDA806Q35793341-6BCEDEB0-7029-4950-919E-19E19E2C8B15Q35846896-2E5095DB-B550-4D1B-894F-15852B3DFF48Q36613291-E80186C2-C007-40CC-AFA5-1FE5097C2984Q36629859-6ED06FF6-0311-4EF7-8B4A-BBB12B2B6EFAQ36646681-D5014224-353A-4303-9BEA-D96C74ABE533Q36671789-C3A5546D-C78C-4FCA-95CC-C165CB556504Q36696088-65DC7A96-5E44-4B7F-AFC4-3F6960851807Q36725183-442C513A-C836-41B3-9AFD-B7D165D0B39DQ36749673-969790BC-4F39-4BF2-9C79-951CF8ECBC77Q36761689-DD158EDC-EE58-4ACF-ADAF-10FACBAF9627Q38361296-F8F2D658-3071-4275-AF6A-C129051DE5F2Q41866277-875EB76E-200D-40C7-AC9E-84454809EAE4Q47435083-F0D53AC9-94B4-42BA-9E74-AEECCCC79B21
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
@ast
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
@en
type
label
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
@ast
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
@en
prefLabel
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
@ast
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
@en
P1476
HER-2/neu (c-erb-B2) gene and protein in breast cancer
@en
P2093
P304
P407
P433
P577
1999-07-01T00:00:00Z